Syncom Formulations (India) Limited (BOM:524470)

India flag India · Delayed Price · Currency is INR
13.95
-0.10 (-0.71%)
At close: Apr 28, 2026
-18.13%
Market Cap 13.11B
Revenue (ttm) 5.03B
Net Income (ttm) 689.58M
Shares Out 940.00M
EPS (ttm) 0.70
PE Ratio 20.02
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 209,688
Average Volume 347,290
Open 13.74
Previous Close 14.05
Day's Range 13.74 - 14.14
52-Week Range 10.21 - 23.46
Beta 0.67
RSI 60.01
Earnings Date May 30, 2026

About BOM:524470

Syncom Formulations (India) Limited manufactures, markets, and sells pharmaceutical formulation products in India and internationally. It operates through Manufacturing and Dealing in Pharmaceutical Drug and Formulations, Trading of Commodities, and Renting of Properties segments. The company offers antibiotics/antiinfectives, anthelmintics, antimalarial, cardiac, derma, gastro, dry syrups and suspensions, creams, gel, ORS, jelly, gynae, inhalers, opthal, ortho, and pediatrics formulations in dosage forms. It also provides life care, evolve, an... [Read more]

Industry Pharmaceutical Preparations
Founded 1988
Employees 744
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524470
Full Company Profile

Financial Performance

In fiscal year 2025, BOM:524470's revenue was 4.65 billion, an increase of 76.55% compared to the previous year's 2.63 billion. Earnings were 494.35 million, an increase of 95.28%.

Financial Statements

News

There is no news available yet.